The SARS-CoV-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine

Rune M. Pedersen*, Line L. Bang, Ditte S. Tornby, Helene Kierkegaard, Anna C. Nilsson, Isik S. Johansen, Claus Bistrup, Thøger G. Jensen, Ulrik S. Justesen, Thomas E. Andersen

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

Original languageEnglish
JournalKidney International
Issue number5
Pages (from-to)1129-1131
Publication statusPublished - Nov 2021


  • Antibodies, Viral
  • COVID-19 Vaccines
  • COVID-19/immunology
  • Humans
  • Kidney Transplantation
  • SARS-CoV-2
  • Transplant Recipients

Cite this